1. Resuscitation, yes or no ? the criteria for transferring patients with hematological malignancies to intensive care. A qualitative study.
- Author
-
Bordier V, Filbet M, Sissoix C, Tricou C, Pereira B, and Guastella V
- Subjects
- Humans, Male, Female, Middle Aged, Intensive Care Units organization & administration, Adult, Aged, Critical Care methods, Critical Care psychology, Critical Care standards, Resuscitation methods, Resuscitation psychology, Resuscitation standards, Decision Making, Hematologic Neoplasms therapy, Hematologic Neoplasms psychology, Qualitative Research, Patient Transfer methods, Patient Transfer standards
- Abstract
Background: Having a hematological malignancy increases the risk of a poor-quality end of life and of dying in intensive care. There is no prognostic score to predict survival on admission to intensive care, but many patients die there. To identify the criteria used in deciding to transfer patients with hematological malignancies to intensive care., Methods: It is a qualitative study. For each patient with a hematological malignancy who died in intensive care, the resuscitator and hematologist involved in the decision to transfer the patient to intensive care were contacted. The study ran at Lyon Sud Hospital Center, between 1 November 2018 and 30 April 2019. Semi-structured interviews were conducted with data triangulation. Seventeen doctors were contacted, and 17 interviews were conducted., Results: When transferring a patient with a hematological malignancy to intensive care, we identified (i) patient-specific decision criteria for the transfer, namely prognosis of the disease and treatments received, and (ii) decision criteria specific to hematologists and resuscitators, namely difficulty confronting management failure, convenience of transfer to the ICU for hematologists, and attachment of hematologists to their patients., Conclusion: Organizational convenience of transfer to intensive care was the main criterion for hematologists, but emotional attachment favored futile obstinacy, doing everything possible to the detriment of the patient's comfort. It would be useful to make an upstream appraisal of the impact that an early evaluation of the level of care of patients with hematological malignancies could have on reducing deaths in intensive care., Competing Interests: Declarations. Ethical approval and consent to participate: The HCL Ethics Committee was consulted. The study was registered with the French data protection agency (CNIL) at Hospices Civils de Lyon (HCL) under No. 19–062. The Hospices Civiles de Lyon (HCL) Ethics Committee did not feel that its approval was necessary and waived the need of informed consent because the participants were physicians and the study concerned situations involving deceased patients. All methods were carried out in accordance with relevant guidelines and regulations in ethics approval and consent to participate section. All methods were carried out in accordance with Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF